Taiwan News22h
Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...
KTU "AI textbook without effectiveness verification...Completely Rejected Adoption and Use"
The Korean Teachers and Education Workers' Union has decided to reject all artificial intelligence (AI) digital textbooks, which the Ministry of Education ...